Search Results
10
Everything
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
March 20, 2025 08:30 ET
|
Stemline Therapeutics, Inc.
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around...
Stemline Announces Four SL-401 Presentations at Upcoming ASH Meeting
November 01, 2017 09:02 ET
|
Stemline Therapeutics, Inc.
NEW YORK, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers,...